Measles-containing-vaccine second-dose (MCV2) immunization coverage in Lower-middle income (World Bank)
Lower-middle income (World Bank): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 79.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Lower-middle income (World Bank), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Lower-middle income (World Bank) recorded 79.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025. That is the highest value across all 26 years on record.
That represents a change of up 2.6% on the previous year and up 46.3% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Lower-middle income (World Bank) peaked at 79.0% in 2025 and was at its lowest, 5.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 5.0% | — |
| 2001 | 6.0% | +20.0% |
| 2002 | 5.0% | -16.7% |
| 2003 | 5.0% | +0.0% |
| 2004 | 7.0% | +40.0% |
| 2005 | 6.0% | -14.3% |
| 2006 | 6.0% | +0.0% |
| 2007 | 6.0% | +0.0% |
| 2008 | 6.0% | +0.0% |
| 2009 | 9.0% | +50.0% |
| 2010 | 10.0% | +11.1% |
| 2011 | 23.0% | +130.0% |
| 2012 | 31.0% | +34.8% |
| 2013 | 40.0% | +29.0% |
| 2014 | 47.0% | +17.5% |
| 2015 | 54.0% | +14.9% |
| 2016 | 60.0% | +11.1% |
| 2017 | 62.0% | +3.3% |
| 2018 | 65.0% | +4.8% |
| 2019 | 68.0% | +4.6% |
| 2020 | 68.0% | +0.0% |
| 2021 | 69.0% | +1.5% |
| 2022 | 74.0% | +7.2% |
| 2023 | 75.0% | +1.4% |
| 2024 | 77.0% | +2.7% |
| 2025 | 79.0% | +2.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.1% | 5.0% | 9.0% | 10 |
| 2010s | 46.0% | 10.0% | 68.0% | 10 |
| 2020s | 73.7% | 68.0% | 79.0% | 6 |
More health data for Lower-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 7,080 (2025)
- Total tetanus - number of reported cases, gaps filled 16,092 (2025)
- Diphtheria - number of reported cases, gaps filled 20,601 (2025)
- Measles - number of reported cases, gaps filled 97,321 (2025)
- Measles - number of reported cases, annual growth rate -8.83 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -40.79 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 117.14 % change on previous year (2025)
- Diphtheria - number of reported cases 20,601 (2025)
- Total tetanus - number of reported cases 16,092 (2025)
- Pertussis - number of reported cases 7,080 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Lower-middle income (World Bank)?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Lower-middle income (World Bank) was 79.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Lower-middle income (World Bank)?
- The highest recorded value was 79.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 5.0% in 2000.
- How does Lower-middle income (World Bank) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Lower-middle income (World Bank) ranks 6th out of 11 groups with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Lower-middle income (World Bank)?
- Over the last ten years it is up 46.3%. The long-run trend across the full record is volatile.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).